Jinsai Shang

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Signal transduction and targeted therapy

Biomolecules

bioRxiv : the preprint server for biology

Nature communications

Bioland Laboratory (Guangzhou Regenerative Medicine and Health-Guangdong Laboratory)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bioland Laboratory (Guangzhou Regenerative Medicine and Health-Guangdong Laboratory) Sep 03 2020

China

Principal Investigator :: Center for Neuro-Metabolism and Regeneration Research (CNMR)

The Scripps Research Institute Aug 01 2015

United States

Research Associate :: Department of Integrative Structural and Computational Biology

Publications

Jiyun Zhang, Miru Tang, Jinsai Shang
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges. Biomolecules 14 (2) (2024)
Qi Yang, Bao Xue, Fengjiang Liu, Yongzhi Lu, Jielin Tang, Mengrong Yan, Qiong Wu, Ruyi Chen, Anqi Zhou, Lijie Liu, Junjun Liu, Changbin Qu, Qingxin Wu, Muqing Fu, Jiayi Zhong, Jianwei Dong, Sijie Chen, Fan Wang, Yuan Zhou, Jie Zheng, Wei Peng, Jinsai Shang, Xinwen Chen
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein. Signal transduction and targeted therapy 9 (1) (2024)
Qi Yang, Bao Xue, Fengjiang Liu, Yongzhi Lu, Jielin Tang, Mengrong Yan, Qiong Wu, Ruyi Chen, Anqi Zhou, Lijie Liu, Junjun Liu, Changbin Qu, Qingxin Wu, Muqing Fu, Jiayi Zhong, Jianwei Dong, Sijie Chen, Fan Wang, Yuan Zhou, Jie Zheng, Wei Peng, Jinsai Shang, Xinwen Chen
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein. Signal transduction and targeted therapy 9 (1) (2024)
Qi Yang, Bao Xue, Fengjiang Liu, Yongzhi Lu, Jielin Tang, Mengrong Yan, Qiong Wu, Ruyi Chen, Anqi Zhou, Lijie Liu, Junjun Liu, Changbin Qu, Qingxin Wu, Muqing Fu, Jiayi Zhong, Jianwei Dong, Sijie Chen, Fan Wang, Yuan Zhou, Jie Zheng, Wei Peng, Jinsai Shang, Xinwen Chen
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein. Signal transduction and targeted therapy 9 (1) (2024)
Qi Yang, Bao Xue, Fengjiang Liu, Yongzhi Lu, Jielin Tang, Mengrong Yan, Qiong Wu, Ruyi Chen, Anqi Zhou, Lijie Liu, Junjun Liu, Changbin Qu, Qingxin Wu, Muqing Fu, Jiayi Zhong, Jianwei Dong, Sijie Chen, Fan Wang, Yuan Zhou, Jie Zheng, Wei Peng, Jinsai Shang, Xinwen Chen
Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein. Signal transduction and targeted therapy 9 (1) (2024)
Jinsai Shang, Douglas J Kojetin
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ. bioRxiv : the preprint server for biology (2024)
Jiyun Zhang, Miru Tang, Jinsai Shang
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges. Biomolecules 14 (2) (2024)
Jinsai Shang, Douglas J Kojetin
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ. bioRxiv : the preprint server for biology (2024)
Jiyun Zhang, Miru Tang, Jinsai Shang
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges. Biomolecules 14 (2) (2024)
Jiyun Zhang, Miru Tang, Jinsai Shang
PPARγ Modulators in Lung Cancer: Molecular Mechanisms, Clinical Prospects, and Challenges. Biomolecules 14 (2) (2024)
Jinsai Shang, Douglas J Kojetin
Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARγ. bioRxiv : the preprint server for biology (2024)
Yuanjun He, Di Zhu, Kevin Greenman, Claudia Ruiz, Jinsai Shang, Qun Lu, Douglas J Kojetin, Robert Drakas, Michael D Cameron, Mike Lizarzaburu, Laura A Solt, Theodore M Kamenecka
Structure-Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 ( 34 ) for Autoimmune Disorders. Journal of medicinal chemistry (2023)
Sarah A Mosure, Timothy S Strutzenberg, Jinsai Shang, Paola Munoz-Tello, Laura A Solt, Patrick R Griffin, Douglas J Kojetin
Structural basis for heme-dependent NCoR binding to the transcriptional repressor REV-ERBβ. Science advances 7 (5) (2021)
Jinsai Shang, Sarah A Mosure, Jie Zheng, Richard Brust, Jared Bass, Ashley Nichols, Laura A Solt, Patrick R Griffin, Douglas J Kojetin
A molecular switch regulating transcriptional repression and activation of PPARγ. Nature communications 11 (1) (2020)
Jinsai Shang, Richard Brust, Patrick R Griffin, Theodore M Kamenecka, Douglas J Kojetin
Quantitative structural assessment of graded receptor agonism. Proceedings of the National Academy of Sciences of the United States of America 116 (44) (2019)
Sarah A Mosure, Jinsai Shang, Jerome Eberhardt, Richard Brust, Jie Zheng, Patrick R Griffin, Stefano Forli, Douglas J Kojetin
Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone. Journal of medicinal chemistry 62 (4) (2019)
Jinsai Shang, Richard Brust, Sarah A Mosure, Jared Bass, Paola Munoz-Tello, Hua Lin, Travis S Hughes, Miru Tang, Qingfeng Ge, Theodore M Kamenekca, Douglas J Kojetin
Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ. eLife 7 (2018)
Richard Brust, Jinsai Shang, Jakob Fuhrmann, Sarah A Mosure, Jared Bass, Andrew Cano, Zahra Heidari, Ian M Chrisman, Michelle D Nemetchek, Anne-Laure Blayo, Patrick R Griffin, Theodore M Kamenecka, Travis S Hughes, Douglas J Kojetin
A structural mechanism for directing corepressor-selective inverse agonism of PPARγ. Nature communications 9 (1) (2018)

Jinsai Shang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jinsai Shang